Advertisement

Increased risk of cardiac arrhythmias with cannabis use – More studies are needed

  • Ran Abuhasira
    Affiliations
    Cannabis Clinical Research Institute and Clinical Research Center, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
    Search for articles by this author
  • Victor Novack
    Correspondence
    Corresponding author.
    Affiliations
    Cannabis Clinical Research Institute and Clinical Research Center, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
    Search for articles by this author
Published:August 06, 2020DOI:https://doi.org/10.1016/j.ejim.2020.08.008
      The regulations of medical and recreational cannabis are constantly changing in recent years, both in United States and in many other countries around the world [
      • Abuhasira R
      • Shbiro L
      • Landschaft Y
      Medical use of cannabis and cannabinoids containing products – regulations in Europe and North America.
      ]. As a consequence of the changing laws and public opinion, the prevalence of cannabis use is in a steady rise, both in adolescents and young adults, and in older adults [
      • Weinberger AH
      • Zhu J
      • Levin J
      • Barrington-Trimis JL
      • Copeland J
      • Wyka K
      • et al.
      Cannabis use among US adults with anxiety from 2008 to 2017: the role of state-level cannabis legalization.
      ,
      • Cerdá M
      • Sarvet AL
      • Wall M
      • Feng T
      • Keyes KM
      • Galea S
      • et al.
      Medical marijuana laws and adolescent use of marijuana and other substances: alcohol, cigarettes, prescription drugs, and other illicit drugs.
      ,
      • Han BH
      • Palamar JJ
      Marijuana use by middle-aged and older adults in the United States, 2015–2016.
      ,
      • Abuhasira R
      • Ron A
      • Sikorin I
      • Novack V
      Medical cannabis for older patients—treatment protocol and initial results.
      ]. The potency of recreational cannabis is also on the rise, reflected by increase in the concentration of Δ9-tetrahydrocannabinol (Δ9-THC) and increase in the Δ9-THC/cannabidiol (CBD) ratio [

      Chandra S, Radwan MM, Chandrani, Majumdar G, Church JC, Tom, et al. New trends in cannabis potency in USA and Europe during the last decade (2008-2017)2019;269:5–15. https://doi.org/10.1007/s00406-019-00983-5.

      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abuhasira R
        • Shbiro L
        • Landschaft Y
        Medical use of cannabis and cannabinoids containing products – regulations in Europe and North America.
        Eur J Intern Med. 2018; 49: 2-6
        • Weinberger AH
        • Zhu J
        • Levin J
        • Barrington-Trimis JL
        • Copeland J
        • Wyka K
        • et al.
        Cannabis use among US adults with anxiety from 2008 to 2017: the role of state-level cannabis legalization.
        Drug Alcohol Depend. 2020; 214108163
        • Cerdá M
        • Sarvet AL
        • Wall M
        • Feng T
        • Keyes KM
        • Galea S
        • et al.
        Medical marijuana laws and adolescent use of marijuana and other substances: alcohol, cigarettes, prescription drugs, and other illicit drugs.
        Drug Alcohol Depend. 2018; 183: 62-68
        • Han BH
        • Palamar JJ
        Marijuana use by middle-aged and older adults in the United States, 2015–2016.
        Drug Alcohol Depend. 2018; 191: 374-381
        • Abuhasira R
        • Ron A
        • Sikorin I
        • Novack V
        Medical cannabis for older patients—treatment protocol and initial results.
        J Clin Med. 2019; 8: 1819
      1. Chandra S, Radwan MM, Chandrani, Majumdar G, Church JC, Tom, et al. New trends in cannabis potency in USA and Europe during the last decade (2008-2017)2019;269:5–15. https://doi.org/10.1007/s00406-019-00983-5.

        • Bar-Lev Schleider L
        • Abuhasira R
        • Novack V
        Medical cannabis: aligning use to evidence-based medicine approach.
        Br J Clin Pharmacol. 2018; 84: 2458-2462
        • Nugent SM
        • Morasco BJ
        • O'Neil ME
        • Freeman M
        • Low A
        • Kondo K
        • et al.
        The effects of cannabis among adults with chronic painandan overview of general harms a systematic review.
        Ann Intern Med. 2017; 167: 319-331
        • Desai R
        • Thakkar S
        • Patel HP
        • Tan BEX
        • Damarlapally N
        • Haque FA
        • et al.
        Higher odds and rising trends in arrhythmia among young cannabis users with comorbid depression.
        Eur J Intern Med. 2020; (0)
      2. Richards JR, Blohm E, Toles KA, Jarman AF, Ely DF, Elder JW. The association of cannabis use and cardiac dysrhythmias: a systematic review. Clin Toxicol2020:1–9. https://doi.org/10.1080/15563650.2020.1743847.

        • Shi S
        • Liu T
        • Liang J
        • Hu D
        • Yang B
        Depression and risk of sudden cardiac death and arrhythmias: a meta-analysis.
        Psychosom Med. 2017; 79: 153-161
        • Koschke M
        • Boettger MK
        • Schulz S
        • Berger S
        • Terhaar J
        • Voss A
        • et al.
        Autonomy of autonomic dysfunction in major depression.
        Psychosom Med. 2009; 71: 852-860
        • Adegbala O
        • Adejumo AC
        • Olakanmi O
        • Akinjero A
        • Akintoye E
        • Alliu S
        • et al.
        Relation of cannabis use and atrial fibrillation among patients hospitalized for heart failure.
        Am J Cardiol. 2018; 122: 129-134
        • Khurshid S
        • Choi SH
        • Weng LC
        • Wang EY
        • Trinquart L
        • Benjamin EJ
        • et al.
        Frequency of cardiac rhythm abnormalities in a half million adults.
        Circ Arrhythmia Electrophysiol. 2018; 11
        • DeFilippis EM
        • Bajaj NS
        • Singh A
        • Malloy R
        • Givertz MM
        • Blankstein R
        • et al.
        Marijuana use in patients with cardiovascular disease.
        J Am Coll Cardiol. 2020; 75: 320-332